Home » Trials » SLCTR/2020/015
Effectiveness of a mindfulness-based intervention on physiological and psychological parameters in pregnant women in Anuradhapura district, Sri Lanka
-
SLCTR Registration Number
SLCTR/2020/015
Date of Registration
The date of last modification
Mar 17, 2025
Scientific Title of Trial
Effectiveness of a mindfulness-based intervention on physiological and psychological parameters in pregnant women in Anuradhapura district, Sri Lanka
Public Title of Trial
Effectiveness of a mindfulness-based intervention on physiological and psychological parameters in pregnant women in Anuradhapura district, Sri Lanka – A randomized controlled trial
Disease or Health Condition(s) Studied
Changes in physiological and psychological parameters in pregnancy
Scientific Acronym
RaPCo-MM
Public Acronym
None
Brief title
Effectiveness of a mindfulness-based intervention in pregnant women
Universal Trial Number
U1111-1245-9167
Any other number(s) assigned to the trial and issuing authority
ERC/2019/31
What is the research question being addressed?
Could an intervention on mindfulness compared to standard antenatal care alone improve physiological and psychological parameters in pregnant women in Anuradhapura district, Sri Lanka?
Type of study
Interventional
Study design
Allocation
Randomized controlled trial
Masking
Masking not used
Control
Standard therapy/practice
Assignment
Parallel
Purpose
Supportive care
Study Phase
Not Applicable
Intervention(s) planned
The study will be conducted in selected MOH areas in Anuradhapura District. In the selected MOH areas, clusters will be randomly allocated to intervention (5 clusters) and control (5 clusters) groups by drawing lots. Therefore, all selected pregnant women in their second trimester registered in a particular antenatal clinic will either receive the mindfulness intervention and routine antenatal care, or only routine antenatal care. Mindfulness based intervention [MBI] will be conducted separately for each cluster at the antenatal clinics on 5 different days.
The intervention will include, a weekly mindfulness intervention which will be carried out for a duration of 6 weeks. Each session will be 1.5 hours to 2 hours long and will be carried out in Sinhala medium. The program will be implemented on the participants by the PI and two other investigators, who have had an appreciable mindfulness practice and training. Each session will comprise of a talk on mindfulness principles, a session on simple mindful movements (Tai Chi introductory exercises) carried out in the seated position and simple meditation sessions, such as awareness of the breath, loving kindness meditation and awareness of the present moment. All other training investigators will be trained by the PI prior to the intervention.
The control group will receive routine antenatal care.
Routine antenatal care: Routine antenatal care at the field level is the care provided to the pregnant mothers by the public health staff mainly including the area medical officer of health (MOH) and the area public health midwife (PHM) according to the maternal care package guidelines given by the Family Health Bureau. The services are provided via antenatal clinics, domiciliary visits by the public health midwife [PHM] and shared care with the curative sector as and when necessary.
Inclusion criteria
Pregnant women,
• of all ages
• registered in ‘pregnant mothers register’ of public health midwives and visiting field antenatal clinics in Anuradhapura district.
• who plan to reside in Anuradhapura district throughout their pregnancy
• pregnant women in their second trimester (POA/gestational age 13 – 28 weeks)
Exclusion criteria
Pregnant women,
who are planning to leave the study area prior to delivery
who are unable to read or understand spoken Sinhala language
with a history of or current psychotic disease
with severe physical illnesses limiting mobility
Primary outcome(s)
1.
Mindfulness will be assessed using three questionnaires (translated to Sinhala and validated); 1. Mindful Assessment Awareness Scale – State (MAAS – State)
|
[ One week prior to introducing the intervention and just after the 6th week of conducting the intervention ] |
Secondary outcome(s)
1.
Outcomes will be measured in both intervention and control groups Respiratory rate using palpatory method with physician’s hand on participant’s epigastrium |
[ One week prior to introducing the intervention and just after the 6th week of conducting the intervention ] |
2.
Outcomes will be measured in both intervention and control groups Pulse rate using palpatory method, radial pulse |
[ One week prior to introducing the intervention and just after the 6th week of conducting the intervention ] |
3.
Outcomes will be measured in both intervention and control groups Arterial blood pressure using Aneroid sphygmomanometer, stethoscope, auscultatory method |
[ One week prior to introducing the intervention and just after the 6th week of conducting the intervention ] |
4.
Outcomes will be measured in both intervention and control groups Serum cortisol level using Chemiluminescence immunoassay. Machine used: Liaison Diasorian |
[ One week prior to introducing the intervention and just after the 6th week of conducting the intervention ] |
5.
|
[] |
6.
|
[] |
7.
|
[] |
8.
|
[] |
9.
|
[] |
10.
|
[] |
11.
|
[] |
12.
|
[] |
13.
|
[] |
14.
|
[] |
15.
|
[] |
16.
|
[] |
17.
|
[] |
18.
|
[] |
19.
|
[] |
20.
|
[] |
21.
|
[] |
22.
|
[] |
23.
|
[] |
24.
|
[] |
25.
|
[] |
26.
|
[] |
27.
|
[] |
28.
|
[] |
29.
|
[] |
30.
|
[] |
31.
|
[] |
32.
|
[] |
33.
|
[] |
34.
|
[] |
35.
|
[] |
36.
|
[] |
37.
|
[] |
38.
|
[] |
39.
|
[] |
40.
|
[] |
41.
|
[] |
42.
|
[] |
43.
|
[] |
44.
|
[] |
45.
|
[] |
46.
|
[] |
47.
|
[] |
48.
|
[] |
49.
|
[] |
50.
|
[] |
51.
|
[] |
52.
|
[] |
53.
|
[] |
54.
|
[] |
55.
|
[] |
56.
|
[] |
57.
|
[] |
58.
|
[] |
59.
|
[] |
60.
|
[] |
61.
|
[] |
62.
|
[] |
63.
|
[] |
64.
|
[] |
65.
|
[] |
66.
|
[] |
67.
|
[] |
68.
|
[] |
69.
|
[] |
70.
|
[] |
71.
|
[] |
72.
|
[] |
73.
|
[] |
74.
|
[] |
75.
|
[] |
76.
|
[] |
77.
|
[] |
78.
|
[] |
79.
|
[] |
80.
|
[] |
81.
|
[] |
82.
|
[] |
83.
|
[] |
84.
|
[] |
85.
|
[] |
86.
|
[] |
87.
|
[] |
88.
|
[] |
89.
|
[] |
90.
|
[] |
91.
|
[] |
92.
|
[] |
93.
|
[] |
94.
|
[] |
95.
|
[] |
96.
|
[] |
97.
|
[] |
98.
|
[] |
99.
|
[] |
100.
|
[] |
101.
|
[] |
102.
|
[] |
103.
|
[] |
104.
|
[] |
105.
|
[] |
106.
|
[] |
107.
|
[] |
108.
|
[] |
109.
|
[] |
110.
|
[] |
111.
|
[] |
112.
|
[] |
113.
|
[] |
114.
|
[] |
115.
|
[] |
116.
|
[] |
117.
|
[] |
118.
|
[] |
119.
|
[] |
120.
|
[] |
121.
|
[] |
122.
|
[] |
123.
|
[] |
124.
|
[] |
125.
|
[] |
126.
|
[] |
127.
|
[] |
128.
|
[] |
129.
|
[] |
130.
|
[] |
131.
|
[] |
132.
|
[] |
133.
|
[] |
134.
|
[] |
135.
|
[] |
136.
|
[] |
137.
|
[] |
138.
|
[] |
139.
|
[] |
140.
|
[] |
141.
|
[] |
142.
|
[] |
143.
|
[] |
144.
|
[] |
145.
|
[] |
146.
|
[] |
147.
|
[] |
148.
|
[] |
149.
|
[] |
150.
|
[] |
151.
|
[] |
152.
|
[] |
153.
|
[] |
154.
|
[] |
155.
|
[] |
156.
|
[] |
157.
|
[] |
158.
|
[] |
159.
|
[] |
160.
|
[] |
161.
|
[] |
162.
|
[] |
163.
|
[] |
164.
|
[] |
165.
|
[] |
166.
|
[] |
167.
|
[] |
168.
|
[] |
169.
|
[] |
170.
|
[] |
171.
|
[] |
172.
|
[] |
173.
|
[] |
174.
|
[] |
175.
|
[] |
176.
|
[] |
177.
|
[] |
178.
|
[] |
179.
|
[] |
180.
|
[] |
181.
|
[] |
182.
|
[] |
183.
|
[] |
184.
|
[] |
185.
|
[] |
186.
|
[] |
187.
|
[] |
188.
|
[] |
189.
|
[] |
190.
|
[] |
191.
|
[] |
192.
|
[] |
193.
|
[] |
194.
|
[] |
195.
|
[] |
196.
|
[] |
197.
|
[] |
198.
|
[] |
199.
|
[] |
200.
|
[] |
201.
|
[] |
202.
|
[] |
203.
|
[] |
204.
|
[] |
205.
|
[] |
206.
|
[] |
207.
|
[] |
208.
|
[] |
209.
|
[] |
210.
|
[] |
211.
|
[] |
212.
|
[] |
213.
|
[] |
214.
|
[] |
215.
|
[] |
216.
|
[] |
217.
|
[] |
218.
|
[] |
219.
|
[] |
220.
|
[] |
221.
|
[] |
222.
|
[] |
223.
|
[] |
224.
|
[] |
225.
|
[] |
226.
|
[] |
227.
|
[] |
228.
|
[] |
229.
|
[] |
230.
|
[] |
231.
|
[] |
232.
|
[] |
233.
|
[] |
234.
|
[] |
235.
|
[] |
236.
|
[] |
237.
|
[] |
238.
|
[] |
239.
|
[] |
240.
|
[] |
241.
|
[] |
242.
|
[] |
243.
|
[] |
244.
|
[] |
245.
|
[] |
246.
|
[] |
247.
|
[] |
248.
|
[] |
249.
|
[] |
250.
|
[] |
251.
|
[] |
252.
|
[] |
253.
|
[] |
254.
|
[] |
255.
|
[] |
256.
|
[] |
257.
|
[] |
258.
|
[] |
259.
|
[] |
260.
|
[] |
261.
|
[] |
262.
|
[] |
263.
|
[] |
264.
|
[] |
265.
|
[] |
266.
|
[] |
267.
|
[] |
268.
|
[] |
269.
|
[] |
270.
|
[] |
271.
|
[] |
272.
|
[] |
273.
|
[] |
274.
|
[] |
275.
|
[] |
276.
|
[] |
277.
|
[] |
278.
|
[] |
279.
|
[] |
280.
|
[] |
281.
|
[] |
282.
|
[] |
283.
|
[] |
284.
|
[] |
285.
|
[] |
286.
|
[] |
287.
|
[] |
288.
|
[] |
289.
|
[] |
290.
|
[] |
291.
|
[] |
292.
|
[] |
293.
|
[] |
294.
|
[] |
295.
|
[] |
296.
|
[] |
297.
|
[] |
298.
|
[] |
299.
|
[] |
300.
|
[] |
301.
|
[] |
302.
|
[] |
303.
|
[] |
304.
|
[] |
305.
|
[] |
306.
|
[] |
307.
|
[] |
308.
|
[] |
309.
|
[] |
310.
|
[] |
311.
|
[] |
312.
|
[] |
313.
|
[] |
314.
|
[] |
315.
|
[] |
316.
|
[] |
317.
|
[] |
318.
|
[] |
319.
|
[] |
320.
|
[] |
321.
|
[] |
322.
|
[] |
323.
|
[] |
324.
|
[] |
325.
|
[] |
326.
|
[] |
327.
|
[] |
328.
|
[] |
329.
|
[] |
330.
|
[] |
331.
|
[] |
332.
|
[] |
333.
|
[] |
334.
|
[] |
335.
|
[] |
336.
|
[] |
337.
|
[] |
338.
|
[] |
339.
|
[] |
340.
|
[] |
341.
|
[] |
342.
|
[] |
343.
|
[] |
344.
|
[] |
345.
|
[] |
346.
|
[] |
347.
|
[] |
348.
|
[] |
349.
|
[] |
350.
|
[] |
351.
|
[] |
352.
|
[] |
353.
|
[] |
354.
|
[] |
355.
|
[] |
356.
|
[] |
357.
|
[] |
358.
|
[] |
359.
|
[] |
360.
|
[] |
361.
|
[] |
362.
|
[] |
363.
|
[] |
364.
|
[] |
365.
|
[] |
366.
|
[] |
367.
|
[] |
368.
|
[] |
369.
|
[] |
370.
|
[] |
371.
|
[] |
372.
|
[] |
373.
|
[] |
374.
|
[] |
375.
|
[] |
376.
|
[] |
377.
|
[] |
378.
|
[] |
379.
|
[] |
380.
|
[] |
381.
|
[] |
382.
|
[] |
383.
|
[] |
384.
|
[] |
385.
|
[] |
386.
|
[] |
387.
|
[] |
388.
|
[] |
389.
|
[] |
390.
|
[] |
391.
|
[] |
392.
|
[] |
393.
|
[] |
394.
|
[] |
395.
|
[] |
396.
|
[] |
397.
|
[] |
398.
|
[] |
399.
|
[] |
400.
|
[] |
401.
|
[] |
402.
|
[] |
403.
|
[] |
404.
|
[] |
405.
|
[] |
406.
|
[] |
407.
|
[] |
408.
|
[] |
409.
|
[] |
410.
|
[] |
411.
|
[] |
412.
|
[] |
413.
|
[] |
414.
|
[] |
415.
|
[] |
416.
|
[] |
417.
|
[] |
418.
|
[] |
419.
|
[] |
420.
|
[] |
421.
|
[] |
422.
|
[] |
423.
|
[] |
424.
|
[] |
425.
|
[] |
426.
|
[] |
427.
|
[] |
428.
|
[] |
429.
|
[] |
430.
|
[] |
431.
|
[] |
432.
|
[] |
433.
|
[] |
434.
|
[] |
435.
|
[] |
436.
|
[] |
437.
|
[] |
438.
|
[] |
439.
|
[] |
440.
|
[] |
441.
|
[] |
442.
|
[] |
443.
|
[] |
444.
|
[] |
445.
|
[] |
446.
|
[] |
447.
|
[] |
448.
|
[] |
449.
|
[] |
450.
|
[] |
451.
|
[] |
452.
|
[] |
453.
|
[] |
454.
|
[] |
455.
|
[] |
456.
|
[] |
457.
|
[] |
458.
|
[] |
459.
|
[] |
460.
|
[] |
461.
|
[] |
462.
|
[] |
463.
|
[] |
464.
|
[] |
465.
|
[] |
466.
|
[] |
467.
|
[] |
468.
|
[] |
469.
|
[] |
470.
|
[] |
471.
|
[] |
472.
|
[] |
473.
|
[] |
474.
|
[] |
475.
|
[] |
476.
|
[] |
477.
|
[] |
478.
|
[] |
479.
|
[] |
Target number/sample size
56 (28 per arm)
Countries of recruitment
Sri Lanka
Anticipated start date
2021-06-01
Anticipated end date
2021-12-31
Date of first enrollment
Date of study completion
Recruitment status
Pending
Funding source
World Bank AHEAD project
Regulatory approvals
Not applicable
Status
Approved
Date of Approval
2020-01-01
Approval number
ERC/2019/31
Details of Ethics Review Committee
Name: | Ethics Review Committee of the Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka. |
Institutional Address: | Ethics Review Committee, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura 50008. |
Telephone: | +94(0)25 2053633 |
Email: | ethicsreviewcommittee@gmail.com |
Contact person for Scientific Queries/Principal Investigator
Dr. Sujanthi Priyanka Wickramage
Head/Senior Lecturer in Physiology
Department of Physiology,
Faculty of Medicine and Allied Sciences,
Rajarata University of Sri Lanka,
Saliyapura 50008
0252234612
0776240369
sujanthi.wickramage@gmail.com
Contact Person for Public Queries
Dr. Sujanthi Priyanka Wickramage
Head/Senior Lecturer in Physiology
Department of Physiology,
Faculty of Medicine and Allied Sciences,
Rajarata University of Sri Lanka,
Saliyapura 50008
0252234612
0776240369
sujanthi.wickramage@gmail.com
Primary study sponsor/organization
Prof Tusitha Abeythunga
Lead Academic Expert Research and Innovation
Prof Tushitha Abeythunga,
Lead Academic Expert Research and Innovation,
Accelerating Higher Education Expansion and Development (AHEAD) Operation
rdic.ahead@gmail.com
Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?
Yes
IPD sharing plan description
Individual participant data that underlie the results being reported, after de-identification (text, tables, figures and appendices) will be shared. Statistical analysis will be included. Data will be shared following the publication. Data will be shared with researchers who provide a methodologically sound proposal. Data will be shared to achieve the aims in an approved proposal. Data will be available for 5 years from the time of publication.
Study protocol available
No
Protocol version and date
Not Available
Protocol URL
Not Available
Results summary available
No
Date of posting results
Date of study completion
Final sample size
Date of first publication
Link to results
Brief summary of results